No. | Drug Name | Decision |
1 | Apixaban 2.5mg Film Coated Tablet (Eliquis) | Agreed to add Neurologist as prescriber. |
2 | Apixaban 2.5mg Film Coated Tablet (Eliquis) | Agreed to add Nephrologist as prescriber. |
3 | Apixaban 5mg Film Coated Tablet (Eliquis) | Agreed to add Neurologist as prescriber. |
4 | Apixaban 5mg Film Coated Tablet (Eliquis) | Agreed to add Nephrologist as prescriber. |
5 | Bevacizumab 100mg Injection (MVASI) | Rejected as Special Formulary. |
6 | Bevacizumab 400mg Injection (MVASI) | Agreed to defer to next D&T meeting.
To get input from Ophthalmology team regarding MVASI use in the treatment of Age-related Macular Degeneration (AMD). |
7 | Daptomycin 500mg Injection (Cubicin) | Agreed to accept as Standard Formulary.
Limited to 8 patients per year.
Agreed to remove Tigecycline from the UMMC Formulary. |
8 | Desmopressin 4mcg Injection (Minirin) | Agreed to add Intensive Care Team as prescriber. |
9 | Dulaglutide 0.75mg Injection
(Trulicity) | Rejected as Special Formulary. Dulaglutide 1.5mg available in Special Formulary. |
10 | Dulaglutide 1.5mg Injection
(Trulicity)
| Agreed to add Cardiologist & Nephrologist (for patients with eGFR 15-30 only) as prescriber. |
11 | Erythromycin 500mg Injection | Agreed to accept as Standard Formulary. |
12 | Evolocumab 140mg Injection (Repatha) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. |
13 | Guselkumab 100mg Injection (Tremfya) | Agreed to accept as Special Formulary. |
14 | Rivaroxaban 2.5mg Tablet (Xarelto) | Rejected to add in new strength with new indication and new prescriber. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. |
15 | Trastuzumab 600mg/5mL Inj (Herceptin SC) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. |
16 | Ustekinumab 130mg/26mL Injection (Stelara)
| Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. |
17 | Ustekinumab 90mg/1.0mL Injection (Stelara) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. |
18 | Iron Hydroxide Sucrose Complex 100mg/5mL Injection
(Venofer) | Agreed to remove Venofer from the UMMC Formulary. Agreed to accept Monofer as Special Formulary. |
19 | Oxymetholone 50mg Tablet | Agreed to remove Oxymetholone 50mg tablet from the UMMC Formulary. |
20 | Sodium chloride 0.9% Eye Drops | Agreed to remove Sodium Chloride 0.9% Eye Drops from the UMMC Formulary. |
21 | Tigecycline 50mg Injection (Tygacil) | Agreed to remove Tigecycline from the UMMC Formulary.
Agreed to accept Daptomycin as Standard Formulary. |
22 | Deferasirox 125mg Dispersible Tablet
(EXJADE) | Rejected from procurement discontinuation.
EXJADE continues as Special Formulary. Pharmacy to monitor stock movement closely to prevent wastage due to expired stock. |
23 | Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer) | Agreed to accept as Special Formulary.
Agreed to delete Venofer from the UMMC Formulary. |
